RESÚMENES JUNIO 2005

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: An observational study
Jorge M Tamayo, Karis Roman, Juan J Fumero and Maria Rivas
BMC Psychiatry 2005, 5:28

 

Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study

Steven E. Bruce, Kimberly A. Yonkers, Michael W. Otto, Jane L. Eisen, Risa B. Weisberg, Maria Pagano, M. Tracie Shea, and Martin B. Keller

Am J Psychiatry 162:1179-1187, June 2005

Risk, psychiatry and the military

SIMON WESSELY

The British Journal of Psychiatry (2005) 186: 459-466

The effect of escitalopram on sleep problems in depressed patients
Lader M, Andersen HF, Baekdal T

Hum Psychopharmacol. 2005 May 24; [Epub ahead of print]

 

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials
Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV

Hum Psychopharmacol. 2005 May 24; [Epub ahead of print]

 

Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?

Susan L. McElroy, Renu Kotwal, Paul E. Keck, Jr. and Hagop S. Akiskal

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 107-127

 

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues

Claudia Kohl, Thomas Walch, Regina Huber, Georg Kemmler, Gabriele Neurauter, Dietmar Fuchs, Elisabeth Sölder, Hans Schröcksnadel and Barbara Sperner-Unterweger

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 135-142

 

A history of major depressive disorder and the response to stress

Mark A. Ilgen and Kent E. Hutchison

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 143-150

 

Parental death and bipolar disorder: A robust association was found in early maternal suicide

Kenji J. Tsuchiya, Esben Agerbo and Preben B. Mortensen

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 151-159

 

Defining the boundaries of atypical depression: Evidence from the HPA axis supports course of illness distinctions

Jonathan W. Stewart, Frederic M. Quitkin, Patrick J. McGrath and Donald F. Klein

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 161-167

 

Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: Results of a naturalistic clinical trial

Dennis A. Revicki, Robert M.A. Hirschfeld, Eileen P. Ahearn, Richard H. Weisler, Cynthia Palmer and Paul E. Keck, Jr

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 183-193

 

Clinical impact of late diagnose of bipolar disorder

Fernando Kratz Gazalle, Ana Cristina Andreazza, Keila Maria Ceresér, Pedro Curi Hallal, Aida Santin and Flávio Kapczinski

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 313-316

 

Acute tryptophan depletion in depressed patients treated with a selective serotonin–noradrenalin reuptake inhibitor: Augmentation of antidepressant response?

Linda Booij, A.J. Willem Van der Does, P.M. Judith Haffmans and Wim J. Riedel

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 305-311

 

Prediction of response to ECT with routinely collected data in major depression

Iris M. de Vreede, Huibert Burger and Irene M. van Vliet

Journal of Affective Disorders. Volume 86, Issues 2-3, June 2005, Pages 323-327

 

Risk factors of major depression in the elderly

Reinhard Heun and Sandra Hein

European Psychiatry. Volume 20, Issue 3, May 2005, Pages 199-204

The impact of depression is unevenly distributed in the population

Dag Isacson, Kerstin Bingefors and Lars von Knorring

European Psychiatry. Volume 20, Issue 3, May 2005, Pages 205-212

 

The psychobiology of anxiety

Jean Kim and Jack Gorman

Clinical Neuroscience Research. Volume 4, Issues 5-6, May 2005, Pages 335-347

A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder
Masui T, Hashimoto R, Kusumi I, Suzuki K, Tanaka T, Nakagawa S, Kunugi H, Koyama T

Int J Neuropsychopharmacol. 2005 Jun 1:1-6

 

Modafinil augmentation in depressed patients with partial response to antidepressants: A pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92)
Niels-Anton Rasmussen , Palle Schrøder , Lis Raabæk Olsen , Mogens Brødsgaard , Mogens Undén , Per Bech

Nordic Journal of Psychiatry. Volume 59, Number 3 / June 2005: 173 - 178

 

 

 

Antidepressant drug use and suicide prevention
Göran Isacsson and Charles L. Rich

International Review of Psychiatry. Volume 17, Number 3 / June 2005: 153 - 162

 

 

 

Antidepressant drug use & the risk of suicide
David Healy and Graham Aldred

International Review of Psychiatry. Volume 17, Number 3 / June 2005: 163 - 172

 

Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study
Fineberg, Naomi A; Sivakumaran, Thanusha; Roberts, Anne; Gale, Tim

International Clinical Psychopharmacology. 20(4):223-226, July 2005

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
Shelton, Charles; Entsuah, Richard; Padmanabhan, S. Krishna; Vinall, Phillip

International Clinical Psychopharmacology. 20(4):233-238, July 2005

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

Yatham, Lakshmi N; Kennedy, Sidney H; O'Donovan, Claire; Parikh, Sagar; MacQueen, Glenda; McIntyre, Roger; Sharma, Verinder; Silverstone, Peter; Alda, Martin; Baruch, Philippe; Beaulieu, Serge; Daigneault, Andree; Milev, Roumen; Young, L. Trevor; Ravindran, Arun; Schaffer, Ayal; Connolly, Mary; Gorman, Chris P

Bipolar Disorders, June 2005, vol. 7, no. s3, pp. 5-69

 

Operation of the Schizophrenia Susceptibility Gene, Neuregulin 1, Across Traditional Diagnostic Boundaries to Increase Risk for Bipolar Disorder

Elaine K. Green, Rachel Raybould, Stuart Macgregor, Katherine Gordon-Smith, Jess Heron, Sally Hyde, Detelina Grozeva, Marian Hamshere, Nigel Williams, Michael J. Owen, Michael C. O’Donovan, Lisa Jones, Ian Jones, George Kirov, Nick Craddock

Arch Gen Psychiatry. 2005;62:642-648

 

The mood spectrum: improving the diagnosis of bipolar disorder

Jules Angst and Giovanni Cassano

Bipolar Disorders. Volume 7 Issue s4 Page 4  - August 2005

Translating knowledge of genetics and pharmacology into improving everyday practice

Lakshmi N Yatham

Bipolar Disorders. Volume 7 Issue s4 Page 13  - August 2005

Atypical antipsychotics: newer options for mania and maintenance therapy

Eduard Vieta and Jose M GoikoleaBipolar

Bipolar Disorders. Volume 7 Issue s4 Page 21  - August 2005

Bipolar depression: a new role for atypical antipsychotics?

Paul E Keck Jr

Bipolar Disorders. Volume 7 Issue s4 Page 34  - August 2005

 

Obsessive–compulsive disorder and spectrum across the life span
Eric Hollander

International Journal of Psychiatry in Clinical Practice. Volume 9, Number 2 / June 2005: 79 - 86

 

 

Mirtazapine versus paroxetine in panic disorder: an open study
F. Montañés-Rada, M.T. De Lucas-Taracena, S. Sánchez-Romero

International Journal of Psychiatry in Clinical Practice. Volume 9, Number 2 / June 2005: 87 - 93

 

 

Prevalence of suicidality during pregnancy and the postpartum

V. Lindahl, J. L. Pearson and L. Colpe

Archives of Women's Mental Health 2005; Volume 8, Number 2: 77 - 87

 

 

Depressive symptoms in early pregnancy, two months and one year postpartum-prevalence and psychosocial risk factors in a national Swedish sample

C. Rubertsson, B. Wickberg, P. Gustavsson and I. Rådestad

Archives of Women's Mental Health 2005; Volume 8, Number 2: 97 - 104

 

Are There Differences in the Symptoms that Respond to a Selective Serotonin or Norepinephrine Reuptake Inhibitor?

J. Craig Nelson, Laura Portera and Andrew C. Leon

Biological Psychiatry. Volume 57, Issue 12, 15 June 2005, Pages 1535-1542

 

Symptoms of Late-Life Depression. Frequency and Change During Treatment

J. Craig Nelson, Cathryn M. Clary, Andrew C. Leon, and Lon S. Schneider

Am J Geriatr Psychiatry 13:520-526, June 2005

 

Remission Rates With 3 Consecutive Antidepressant Trials: Effectiveness for Depressed Outpatients

Frederic M. Quitkin, Patrick J. McGrath, Jonathan W. Stewart, Deborah Deliyannides, Bonnie P. Taylor, Carrie A. Davies, and Donald F. Klein

J Clin Psychiatry 2005;66:670-676

 

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

Pedro L. Delgado, Stephen K. Brannan, Craig H. Mallinckrodt, Pierre V. Tran, Robert K. McNamara, Fujun Wang, John G. Watkin, and Michael J. Detke

J Clin Psychiatry 2005;66:686-692

 

Dual Reuptake Inhibitors Incur Lower Rates of Tachyphylaxis Than Selective Serotonin Reuptake Inhibitors: A Retrospective Study

Michael A. Posternak, and Mark Zimmerman

J Clin Psychiatry 2005;66:705-707

 

Double-Blind Comparison of Sertraline and Placebo in Stroke Patients With Minor Depression and Less Severe Major Depression

Veronica Murray, Magnus von Arbin, Aniko Bartfai, Anna-Lena Berggren, Anne-Marie Landtblom, Jöns Lundmark, Per Näsman, Jan-Edvin Olsson, Margareta Samuelsson, Andreas Terént, Riitta Varelius, Marie Åsberg, and Björn Mårtensson

J Clin Psychiatry 2005;66:708-716

 

Omega-3 Eicosapentaenoic Acid in Bipolar Depression: Report of a Small Open-Label Study

Yamima Osher, Yuly Bersudsky, and R. H. Belmaker

J Clin Psychiatry 2005;66:726-729

 

Risperidone and Haloperidol Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder: A Crossover Study

Xiaohua Li, Roberta S. May, Lelland C. Tolbert, Warren T. Jackson, James M. Flournoy, and Lewis R. Baxter

J Clin Psychiatry 2005;66:736-743

 

An 11- to 13-Year Follow-Up of 75 Subjects With Obsessive-Compulsive Disorder

Y. C. Janardhan Reddy, Sujit Maxim D'Souza, Chandrashekhar Shetti, Thennarasu Kandavel, Sandip Deshpande, Suresh Badamath, and Srinivas Singisetti

J Clin Psychiatry 2005;66:744-749

 

Antidepressant Drug Consumption and Public Health Indicators in Italy, 1955 to 2000

Giuseppe Guaiana, Margherita Andretta, Letizia Corbari, Mersia Mirandola, Adriano Sorio, Barbara D'Avanzo, and Corrado Barbui

J Clin Psychiatry 2005;66:750-755

 

Estrogen Augmentation of Antidepressants in Perimenopausal Depression: A Pilot Study

Melinda L. Morgan, Ian A. Cook, Andrea J. Rapkin, and Andrew F. Leuchter

J Clin Psychiatry 2005;66:774-780

 

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

Roger D. Weiss, Michael J. Ostacher, Michael W. Otto, Joseph R. Calabrese, Mark Fossey, Stephen R. Wisniewski, Charles L. Bowden, Andrew A. Nierenberg, Mark H. Pollack, Ihsan M. Salloum, Naomi M. Simon, Michael E. Thase, and Gary S. Sachs, for STEP-BD Investigators

J Clin Psychiatry 2005;66:730-735

 

Depressive Symptoms and Heart Rate Variability in Postmenopausal Women

Chin K. Kim, Susan P. McGorray, Beth A. Bartholomew, Michelle Marsh, Tammy Dicken, Sylvia Wassertheil-Smoller, J. David Curb, Albert Oberman, Judith Hsia, Julius Gardin, Nathan D. Wong, Bruce Barton, Robert P. McMahon, David S. Sheps

Arch Intern Med. 2005;165:1239-1244

 

Long-term Risk for Depressive Symptoms After a Medical Diagnosis

Daniel Polsky, Jalpa A. Doshi, Steven Marcus, David Oslin, Aileen Rothbard, Niku Thomas, Christy L. Thompson

Arch Intern Med. 2005;165:1260-1266

 

Antidepressant drug use and suicide prevention

Isacsson, Göran; Rich, Charles L

International Review of Psychiatry, June 2005, vol. 17, no. 3, pp. 153-162(10)

 

Antidepressant drug use & the risk of suicide

Healy, David; Aldred, Graham

International Review of Psychiatry, June 2005, vol. 17, no. 3, pp. 163-172(10)

 

The epidemiology of long-term benzodiazepine use

Neutel, C. Ineke

International Review of Psychiatry, June 2005, vol. 17, no. 3, pp. 189-197(9)

 

Prevalence and Treatment of Mental Disorders, 1990 to 2003

Ronald C. Kessler, Olga Demler, Richard G. Frank, Mark Olfson, Harold Alan Pincus, Ellen E. Walters, Philip Wang, Kenneth B. Wells, and Alan M. Zaslavsky

NEJM 2005;Volume 352(24):2515-2523

 

Greater MRI lesion volumes in elderly depressed subjects than in control subjects

Warren D. Taylor, James R. MacFall, Martha E. Payne, Douglas R. McQuoid, David C. Steffens, James M. Provenzale and Ranga Rama Krishnan

Psychiatry Research: Neuroimaging. Volume 139, Issue 1, 30 May 2005, Pages 1-7

 

Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer
Loubinoux I, Tombari D, Pariente J, Gerdelat-Mas A, Franceries X, Cassol E, Rascol O, Pastor J, Chollet F.

Neuroimage. 2005 Jun 8; [Epub ahead of print]

 

The Paradox of Quetiapine in Obsessive-Compulsive Disorder

Constantin Tranulis, Stéphane Potvin, Martin Gourgue, Gérard Leblanc, Adham Mancini-Marïe, and Emmanuel Stip

CNS Spectr .2005;10(5):356-361

 

Seasonality and seasonal affective disorder (SAD): An evolutionary viewpoint tied to energy conservation and reproductive cycles

Caroline Davis and Robert D. Levitan

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 3-10

 

Gender, suicidality and bipolar mixed states in adolescents

Steven C. Dilsaver, Franco Benazzi, Zoltan Rihmer, Kareen K. Akiskal and Hagop S. Akiskal

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 11-16

 

Borderline personality disorder characteristics in young adults with recurrent mood disorders: A comparison of bipolar and unipolar depression

Daniel J. Smith, Walter J. Muir and Douglas H.R. Blackwood

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 17-23

Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features

A. John Rush, Mark Zimmerman, Stephen R. Wisniewski, Maurizio Fava, Steven D. Hollon, Diane Warden, Melanie M. Biggs, Kathy Shores-Wilson, Richard C. Shelton, James F. Luther, Brandi Thomas and Madhukar H. Trivedi

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 43-55

 

Suicide in depressive disorders: A retrospective case-control study of 127 suicides

Julia M.A. Sinclair, Louise Harriss, David S. Baldwin and Elizabeth A. King

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 107-113

 

Is treatment-associated hypomania rare with duloxetine: Secondary analysis of controlled trials in non-bipolar depression

David L. Dunner, Deborah N. D'Souza, Daniel K. Kajdasz, Michael J. Detke and James M. Russell

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 115-119

 

Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression—lack of manic induction

Jay D. Amsterdam and Justine Shults

Journal of Affective Disorders. Volume 87, Issue 1, July 2005, Pages 121-130

 

Longitudinal comparison of depressive personality disorder and dysthymic disorder

John C. Markowitz, Andrew E. Skodol, Eva Petkova, Hui Xie, Jianfeng Cheng, David J. Hellerstein, John G. Gunderson, Charles A. Sanislow, Carlos M. Grilo and Thomas H. McGlashan

Comprehensive Psychiatry. Volume 46, Issue 4, July-August 2005, Pages 239-245

 

Relationships between major depressive disorder and comorbid anxiety and personality disorders

Amy Farabaugh, Maurizio Fava, David Mischoulon, Katie Sklarsky, Timothy Petersen and Jonathan Alpert

Comprehensive Psychiatry. Volume 46, Issue 4, July-August 2005, Pages 266-271

 

Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo
Bowden CL, Collins MA, McElroy SL, Calabrese JR, Swann AC, Weisler RH, Wozniak PJ

Neuropsychopharmacology. 2005 Jun 8; [Epub ahead of print]

 

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study

Donatella Marazziti, Chiara Pfanner, Bernardo Dell’osso, Antonio Ciapparelli, Silvio Presta, Giorgio Corretti, Elena Di Nasso, Francesco Mungai, Liliana Dell’osso

Journal of Psychopharmacology, Vol. 19, No. 4, 392-394 (2005)

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Vieta E, Mullen J, Brecher M, Paulsson B, Jones M

Curr Med Res Opin. 2005 Jun;21(6):923-34

 

Bupropion SR for the treatment of postpartum depression: a pilot study

Ruta M. Nonacs, Claudio N. Soares, Adele C. Viguera, Kimberly Pearson, Jennifer R. Poitras and Lee S. Cohen 

The International Journal of Neuropsychopharmacology (2005), 8:3:445-449

 

Evidence-based pharmacotherapy of panic disorder

Abraham Bakker, Anton J. L. M. van Balkom and Dan J. Stein 

The International Journal of Neuropsychopharmacology (2005), 8:3:473-482

 

An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors

Branka Aukst-Margetić and Branimir Margetić

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 29, Issue 5, June 2005, Pages 754-756

 

Adjunctive atomoxetine for residual fatigue in major depressive disorder.
Papakostas GI, Petersen TJ, Burns AM, Fava M

J Psychiatr Res. 2005 Jun 21; [Epub ahead of print]

 

 

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation

E. C. G. van Geffen, J. G. Hugtenburg, E. R. Heerdink, R. P. van Hulten and A. C. G. Egberts

European Journal of Clinical Pharmacology 2005; Volume 61, Number 4: 303 - 307

.

Regresar a RESÚMENES JUNIO 2005